Peptic Ulcer Testing

This report analyzes the worldwide markets for Peptic Ulcers Testing in Millions of US$. The report provides separate comprehensive analytics for the US, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual forecasts are provided for each region for the period of 2001 through 2015. A ten-year historic analysis is also provided for these markets with annual market analytics. The report profiles 29 companies including many key and niche players worldwide such as Beckman Coulter Inc., Kibion AB, Meretek Diagnostics Group of Otsuka America Pharmaceutical, Inc., Meridian Bioscience, Inc., Orion Diagnostica Oy, and Quidel Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

• I. Introduction, Methodology & Product Definitions
  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
  • CAGR Disparities between Historic & Current Data
  • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
  • Peptic Ulcer Tests
• II. Executive Summary
  • 1.Industry Highlights
  • 2.Peptic Ulcers - A Prelude
  • 3.Classification of Peptic Ulcers
    • Gastric Ulcers
    • Duodenal Ulcers
    • Bleeding Peptic Ulcers
  • 4.Conditions or Causes of Peptic Ulcers
    • H. Pylori: The Major Cause of Peptic Ulcers
      • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
      • Excess Acid Production in the Stomach
  • 5.Discovery of H. Pylori - Paradigm Change in Ulcer Treatment
    • H. Pylori - Most Harmful Class I Carcinogen
      • Diseases Caused by H. Pylori Infection
      • Transmission of H. Pylori
      • Eradication of H. Pylori
  • 6.Peptic Ulcer Tests
    • Testing for the Presence of H. Pylori
    • Diagnostic Assays for Detection of H. Pylori
    • Invasive Tests
    • Non-Invasive Tests
    • Tissue Tests: Endoscopy of the Stomach
    • Gastrointestinal Endoscopy: Gold Standard in Diagnoses of Upper GI Diseases
    • The Endoscopic Procedure
    • Blood Test or Serological Test
    • Types of Blood Tests
    • Urea Breath Test (UBT) - The Most Effective Diagnoses for Detection of H. Pylori
    • Urea Breath Test: A Convenient and Affordable Method for Detection & Treatment of Peptic Ulcer
    • Types of Urea Breath Tests
    • Carbon-14-Urea Breath Test
    • Precautionary Measures to be taken Prior to Performance of UBT
    • Federal Legislation Governing the 14C UBT
    • Carbon-13-Urea Breath Test
    • Breath Tests vs Other Diagnostic Assays
    • Barium X-rays
    • Noster System AB's BreathCard and Heliprobe Systems
    • Other Diagnostic Devices and Tests
    • FlexSure. HP
    • QuickView
    • CLOtest
    • CLOser
    • Automated Breath 13C Analyzer (ABCA)
    • Helicobacter Pylori Detection via 13C-UBT
    • Pytest
    • MicroCOUNT
    • EZ-H.P. - The 10 Minute Ulcer Screening Test
    • The Single-Step H. Pylori Test
    • Helisal Rapid Blood Test
  • 7.Treatment of Peptic Ulcers
    • Perplexity of Ulcers
    • A New Page Opens in the Treatment of Ulcers
    • Factors Affecting Peptic Ulcer Conditions
    • Ulcer Therapies for Preventing PUD Recurrence: A Review
    • Advanced-Generation Macrolide Antibiotic Biaxin Therapy
    • The Two-Week Double and Triple Therapies
    • Medication
    • H2-blockers
    • Acid Pump Inhibitors
    • Mucosal Protective Medications
  • 8.Drugs Used to Cure Non-Steroidal Anti- Inflammatory Drug (NSAID) Induced Ulcers
    • Handling NSAID-Induced Ulcers
    • Antacids
    • Antibiotics
    • Side Effects Associated with Antibiotics
    • Misoprostol
    • Cimetidine
    • Mucosta
    • Sucralfate (Carafate)
  • 9.The Need for Surgery
  • 10.Research & Development
    • Probiotics' Effectiveness in Peptic Ulcer Treatment
    • Peptic Ulcer - Relation with Oral Hygiene
    • PPIs Relegate Peptic Ulcer Bleeding
  • 11.Product Innovations/Introductions
    • Sanko Junyaku to Introduce Diagnostic Kit for H. pylori Infection
    • Torrent Pharmaceuticals Releases Nexpro Fast
    • Wyeth Laboratories Launches HeliMet Triple Pack
    • AstraZeneca Introduces Nexium
    • Biomerica Launches Pepgen Test
    • Norton Healthcare Introduces Famotidine Tablets
  • 12.Recent Industry Activity
    • Meretek Strikes Deal with PAML
    • Meretek Diagnostics and OAPI Announce Merger
    • Meridian's Partnership with Merck KGaA
    • Meridian Bags FDA Clearance for Stomach Ulcer Test
    • Kibion AB Acquires Noster System
    • Takeda Pharmaceutical Bags Additional Approval for Takepron
    • UCB's Licensing Agreement with Boryung
    • Eisai and GlaxoSmithKline Sign Co-marketing Agreement
    • Yuhan Gains KFDA Approval for Duodenal Ulcers' Drug
    • Yamanouchi Signs Agreement with Aventis Pharma
    • Oridion Bags FDA Clearance for BreathID H. Pylori Breath Test
    • Quidel Corporation Unveils Latest Version of H. Pylori Test
    • Teikoku Chemical Licenses Technology to Eisai
    • Trinity Biotech Bags FDA Clearance for Uni-Gold Test
    • EPI Bags FDA Clearance for PP-CAP IgA EIA
  • 13.Focus on Select Global Players
    • Beckman Coulter, Inc. (USA)
    • Kibion AB (Sweden)
    • Meretek Diagnostics Group of Otsuka America Pharmaceutical, Inc. (USA)
    • Meridian Bioscience, Inc. (USA)
    • Orion Diagnostica Oy (Finland)
    • Quidel Corporation (USA)
  • 14.Global Market Perspective
• III. Market
  • 1.The United States
    • A. Market Analysis
      • Current and Future Analysis
      • Product Launches/Developments
      • Strategic Corporate Developments
      • Key Players
    • B. Market Analytics
  • 2.Japan
    • A. Market Analysis
      • Current and Future Analysis
      • Strategic Corporate Developments
      • Product Launch
    • B. Market Analytics
  • 3.Europe
    • A. Market Analysis
      • Current and Future Analysis
      • Product Launch
      • Strategic Corporate Development
      • Key Players
    • B. Market Analytics
  • 4.Asia-Pacific
    • A. Market Analysis
      • Current and Future Analysis
      • Product Launch
      • Strategic Corporate Developments
    • B. Market Analytics
  • 5.Latin America
    • Market Analysis
    • Current and Future Analysis
    • Table 18: Latin America Long Term Projections for Peptic Ulcer Testing with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • 6.Rest of World
    • A. Market Analysis
      • Current and Future Analysis
      • Strategic Corporate Development
    • B. Market Analytics
• IV. Competitive Landscape
• List of Tables
  • Table 1: World Recent past, Current & Future Analysis for Peptic Ulcer Testing by Geographic Region - USA, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
  • Table 2: World Long Term Projections for Peptic Ulcer Testing by Geographic Region - USA, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 3: World Historic Review for Peptic Ulcer Testing by Geographic Region - USA, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
  • Table 4: World 15-Year Perspective for Peptic Ulcer Testing by Geographic Region - Percentage Breakdown of Dollar Sales for USA, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1998, 2008, & 2012 (includes corresponding Graph/Chart)
  • Table 5: US Recent past, Current & Future Analysis for Peptic Ulcer Testing with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
  • Table 6: US Long Term Projections for Peptic Ulcer Testing with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 7: US Historic Review for Peptic Ulcer Testing with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
  • Table 8: Japanese Recent past, Current & Future Analysis for Peptic Ulcer Testing with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
  • Table 9: Japanese Long Term Projections for Peptic Ulcer Testing with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 10: Japanese Historic Review for Peptic Ulcer Testing with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
  • Table 11: European Recent past, Current & Future Analysis for Peptic Ulcer Testing Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
  • Table 12: European Long Term Projections for Peptic Ulcer Testing with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 13: European Historic Review for Peptic Ulcer Testing with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
  • Table 14: Asia-Pacific Recent past, Current & Future Analysis for Peptic Ulcer Testing with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
  • Table 15: Asia Pacific Long Term Projections for Peptic Ulcer Testing with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 16: Asia-Pacific Historic Review for Peptic Ulcer Testing with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
  • Table 17: Latin America Recent past, Current & Future Analysis for Peptic Ulcer Testing with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
  • Table 19: Latin America Historic Review for Peptic Ulcer Testing with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
  • Table 20: Rest of World Recent past, Current & Future Analysis for Peptic Ulcer Testing with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
  • Table 21: Rest of World Long Term Projections for Peptic Ulcer Testing with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 22: Rest of World Historic Review for Peptic Ulcer Testing with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)